Academic Radiology
Volume 16, Issue 1 , Pages 54-60 , January 2009

The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma

  • Ruoh-Fang Yen, MD, PhD

      Affiliations

    • Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Ming-Fang Yen, PhD

      Affiliations

    • Institute of Preventive Medicine, National Taiwan University College of Public Health, No. 19, Hsu Chow Road, Taipei, Taiwan
    • ,
  • Ruey-Long Hong, MD, PhD

      Affiliations

    • Department of Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Kai-Yuan Tzen, MD

      Affiliations

    • Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Chun-Ru Chien, MD

      Affiliations

    • Institute of Preventive Medicine, National Taiwan University College of Public Health, No. 19, Hsu Chow Road, Taipei, Taiwan
    • ,
  • Tony Hsiu-Hsi Chen, PhD

      Affiliations

    • Institute of Epidemiology, National Taiwan University College of Public Health, No. 19, Hsu Chow Road, Taipei, Taiwan
    • Corresponding Author InformationAddress correspondence to: T.H.-H.C.

Received 29 May 2008 ,Accepted 19 June 2008.

References 

  1. Huang DP. Epidemiology of nasopharyngeal carcinoma. Ear Nose Throat J. 1990;69:222–225
  2. Liu MT, Hsieh CY, Chang TH, Lin JP, Huang CC, Wang AY. Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol. 2003;33:501–508
  3. Farias TP, Dias FL, Lima RA, et al. Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:794–799
  4. Chong VF, Fan YF. Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology. 1997;202:463–470
  5. Ng SH, Chang JT, Ko SF, Wan YL, Tang LM, Chen WC. MRI in recurrent nasopharyngeal carcinoma. Neuroradiology. 1999;41:855–862
  6. Olmi P, Fallai C, Colagrande S, Giannardi G. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. Int J Radiat Oncol Biol Phys. 1995;32:795–800
  7. Kao CH, ChangLai SP, Chieng PU, Yen RF, Yen TC. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol. 1998;16:3550–3555
  8. Kao CH, Shiau YC, Shen YY, Yen RF. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tompgraphy and conputed tomography (Comparison with 18-fluoro-2-deoxyglucose positron emission tomography). Cancer. 2002;94:1981–1986
  9. Yen RF, Hung RL, Pan MH, Wang YH, Huang KM, Lui LT, et al. 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer. 2003;98:283–287
  10. Ng SH, Chang TC, Chan SC. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med. 2004;45:1669–1676
  11. Yen RF, Hong RL, Tzen KY, Pan MH, Chen TH. Whole-body 18-fluoro-2-deoxyglucose positron emission tomography in recurrent/metastatic nasopharyngeal carcinoma. J Nucl Med. 2005;46:770–774
  12. Tsai MH, Shiau YC, Kao CH, Shen YY, Lin CC, Lee CC. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol. 2002;128:279–282
  13. Goerres GW, Mosna-Firlejczyk K, Steurer J, von Schulthess GK, Bachmann LM. Assessment of clinical utility of 18F-FDG PET in patients with head and neck cancer: a probability analysis. Eur J Nucl Med Mol Imaging. 2003;30:562–571
  14. In:  Gold MR,  Siegel JE,  Russell LB,  Weinstein MC editor. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996;
  15. Elliot R, Payne K. Essentials of economic evaluation in healthcare. London: Pharmaceutical Press; 2005;
  16. Cooper JS, Scott C, Marcial V, et al. The relationship of nasopharyngeal carcinomas and second independent malignancies based on the Radiation Therapy (Oncology Group experience). Cancer. 1991;67:1673–1677
  17. Sham JS, Wei WI, Tai PT, Choy D. Multiple malignant neoplasms in patients with nasopharyngeal carcinoma. Oncology. 1990;47:471–474
  18. Beck JR, Kassirer JP, Pauker SG. A convenient approximation of life expectancy (the “DEALE”): I (Validation of the method). Am J Med. 1982;73:883–888
  19. Chua DT, Wei WI, Sham JS, Chen AC, Au G. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma. Head Neck. 2003;25:585–594
  20. Poon D, Yap sp, Wong ZW, et al. Concurrent chemoradiotherapy in locoregionally recurrent nasopharyneal carcinoma. Int J Radiat Oncol Biol Phys. 2004;59:1312–1318
  21. Shin SS, Ahn YC, Lim do H, Park W, Huh SJ. High dose 3-dimensional re-irradiation for locally recurrent nasopharyngeal cancer. Yonsei Med J. 2004;45:100–106

1 This work was supported in part by grant NSC-94-2314-B-002-113 from the National Science Council, Taiwan.

PII: S1076-6332(08)00419-4

doi: 10.1016/j.acra.2008.06.012

Academic Radiology
Volume 16, Issue 1 , Pages 54-60 , January 2009

Article Tools

* Image Usage & Resolution